Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spyre Therapeutics, Inc. | 160,000 | reported | 20 Mar 2017 | tx 5+325,658−5,658 |
| Oruka Therapeutics, Inc. | 129,600 | reported | 21 Jul 2009 | tx 11+7,500−747,983 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Mar 2017 | GRANT_AWARD | Spyre Therapeutics, Inc. | 160,000 | 0.00 USD | deriv |
| 17 May 2016 | GRANT_AWARD | Spyre Therapeutics, Inc. | 160,000 | 0.00 USD | deriv |
| 12 Apr 2016 | CONVERSION | Spyre Therapeutics, Inc. | 5,658 | 0.00 USD | |
| 12 Apr 2016 | CONVERSION | Spyre Therapeutics, Inc. | 2,857 | 0.00 USD | deriv |
| 12 Apr 2016 | CONVERSION | Spyre Therapeutics, Inc. | 2,801 | 0.00 USD | deriv |
| 20 Jul 2009 | SALE | Oruka Therapeutics, Inc. | 102,000 | 4.44 USD | |
| 21 Jul 2009 | SALE | Oruka Therapeutics, Inc. | 78,800 | 3.94 USD | |
| 17 Jul 2009 | SALE | Oruka Therapeutics, Inc. | 25,000 | 4.19 USD | |
| 11 Jun 2009 | SALE | Oruka Therapeutics, Inc. | 40,700 | 3.84 USD | |
| 15 Jun 2009 | SALE | Oruka Therapeutics, Inc. | 6,100 | 3.90 USD | |
| 12 Jun 2009 | SALE | Oruka Therapeutics, Inc. | 3,800 | 3.94 USD | |
| 08 Jun 2009 | SALE | Oruka Therapeutics, Inc. | 65,708 | 4.21 USD | |
| 10 Jun 2009 | SALE | Oruka Therapeutics, Inc. | 36,000 | 3.96 USD | |
| 09 Jun 2009 | SALE | Oruka Therapeutics, Inc. | 47,500 | 3.99 USD | |
| 01 Jun 2009 | OTHER | Oruka Therapeutics, Inc. | 342,375 | 0.00 USD | |
| 27 Feb 2009 | GRANT_AWARD | Oruka Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |